Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, DuChemBio Co's Enterprise Value is ₩207,410 Mil.
DuChemBio Co's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was ₩5,415 Mil. Therefore, DuChemBio Co's EV-to-EBIT ratio for today is 38.30.
EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, DuChemBio Co's Enterprise Value is ₩207,410 Mil.
DuChemBio Co's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was ₩11,175 Mil. Therefore, DuChemBio Co's EV-to-EBITDA ratio for today is 18.56.
EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, DuChemBio Co's Enterprise Value is ₩207,410 Mil.
DuChemBio Co's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was ₩34,695 Mil. Therefore, DuChemBio Co's EV-to-Revenue ratio for today is 5.98.
DuChemBio Co Enterprise Value Historical Data
The historical data trend for DuChemBio Co's Enterprise Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of DuChemBio Co's Enterprise Value
For the Drug Manufacturers - Specialty & Generic subindustry, DuChemBio Co's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
DuChemBio Co's Enterprise Value Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, DuChemBio Co's Enterprise Value distribution charts can be found below:
* The bar in red indicates where DuChemBio Co's Enterprise Value falls into.
DuChemBio Co Enterprise Value Calculation
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
DuChemBio Co's Enterprise Value for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
DuChemBio Co (XKRX:176750) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
DuChemBio Co's current Enterprise Value is ₩207,410 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. DuChemBio Co's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was ₩5,415 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
DuChemBio Co's current Enterprise Value is ₩207,410 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. DuChemBio Co's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was ₩11,175 Mil.
DuChemBio Co's current Enterprise Value is ₩207,410 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. DuChemBio Co's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was ₩34,695 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
DuChemBio Co Enterprise Value Related Terms
Thank you for viewing the detailed overview of DuChemBio Co's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.
DuChemBio Co Ltd is engaged in manufacturing and sale of radiopharmaceuticals and radioactive medicines. It also imports and sells medical equipment related to nuclear medicines.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
XKRX:176750 has been successfully added to your